Case Report

Opportunistic Infections in Patients with HTLV-1 Infection

Table 1

Laboratory data of two cases.

Case Case

Year 201520102014
C-reactive protein (mg/dL)5.000.175.07
WBC (/µL)1540047002200
Hb (g/dL)13.713.48.6
PLTs (/µL)604K212K149K
AST (U/mL)202333
ALT (U/mL)281935
LDH (122–228) U/mL155185456
Total protein (g/dL)5.97.84.8
Albumin (g/dL)2.64.52.7
BUN (mg/dL)13.37.410.5
Creatinine (mg/dL)1.010.680.67
IgG (mg/dL)1001NTNT
IgA (mg/dL)249NTNT
IgM (mg/dL)76NTNT
A/G ratioNTNT1.58
Ca (8.7–10.3) mg/dL8.79.48.4
sIL-2R (122–496) U/mL4,30429314,058
HTLV-1 Ab (PA < ×16)×1,024×4,096NT
HIV-AbNegativeNegative Negative
HBV-AgNegative Negative Negative
HBV-AbPositive Positive Positive
HCV-AbNegative NegativeNegative
CMV-IgMNegative Negative Negative
CMV antigenemia
(/50 × 103 WBC)
Positive
(89, 91)
Negative
(0)
NT
β-D-glucan (0–20) pg/mL13.03.91,215
Pj-PCR in BAL
(<4 × 101/µg DNA)
NTNT9 × 105

Ag: antigen, Ab: antibody, PA: particle agglutination, NT: not tested, Pj: Pneumocystis jirovecii, and BAL: bronchoalveolar lavage.